- August Stich, group leader, clinical tropical medicine (august.stich@mail.uni-wuerzburg.de)a,
- Paulo M Abel, national coordinatorb,
- Sanjeev Krishna, professor of molecular parasitology and medicinec
- aMedical Mission Institute, Department of Tropical Medicine and Epidemic Control, D-97074 Würzburg, Germany
- bAngotrip Project, Caritas Luanda, Angola
- cDepartment of Infectious Diseases, St George's Hospital Medical School, London SW17 0RE
- Correspondence to: A Stich
- Accepted 6 June 2002
The re-emergence of sleeping sickness presents a major public health problem
Human African trypanosomiasis or sleeping sickness is one of the most important but equally most neglected tropical infections. It is caused by a protozoan, Trypanosoma brucei,which is transmitted to humans through the bite of a tsetse fly (Glossinaspp).1 Patchy distribution of the various vector species confines the disease to some 200 microfoci in sub-Saharan Africa (fig 1). The disease had been successfully controlled by a combination of approaches, including treatment of patients, active case finding, and measures to deal with the vector.2 Since the 1970s, however, the disease has re-emerged as a new epidemic of immense proportions, which, until recently, received little attention from the international community (fig 2). According to the World Health Organization, about 500 000 people already carry trypanosomes and will die if left untreated.3
Summary points
Human African trypanosomiasis is a re-emerging public health problem of epidemic proportions in many parts of rural Africa
The disease is caused by subspecies of Trypanosoma brucei and is transmitted by tsetse flies
Treatment requires admission to hospital and is costly, potentially dangerous, and limited by the widespread appearance of drug resistances
Investment in clinical and pathophysiological research and a broad international commitment to fight trypanosomiasis in Africa are urgently needed
Distribution of human African trypanosomiasis in sub-Saharan Africa
Sources and methods
Extensive literature exists on human African trypanosomiasis and trypanosomes, but it is mostlyconfined to basic sciences and neglects clinical research and the impact of the disease on large parts of the population in rural Africa. One of the countries most affected is Angola. In the north, local health professionals are involved in a control programme implemented through the Catholic charity, Caritas. Some 14 000 patients have already been treated and more than 100 000 examined for the …
Sign in
Personal subscribers, sign in here:
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
Re: How much of a social media profile can doctors have?
Published 13 February 2012
Re: Diagnosis and management of Raynaud’s phenomenon
Published 13 February 2012
Re: Is it unethical for doctors to encourage healthy adults to donate a kidney to a stranger? No
Published 13 February 2012
Re: Report predicts 20 million AIDS orphans in Africa by 2010
Published 13 February 2012
Re: On the impossibility of being expert
Published 13 February 2012
Most responses
Does anyone understand the government’s plan for the NHS? (17 responses)
Published 17 Jan 2012
Bad medicine: medical nutrition (15 responses)
Published 18 Jan 2012
Shared decision making: really putting patients at the centre of healthcare (8 responses)
Published 27 Jan 2012
How much of a social media profile can doctors have? (7 responses)
Published 23 Jan 2012
Why legislation is necessary for my health reforms (7 responses)
Published 1 Feb 2012